MacroGenics Inc
SWB:M55
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
MacroGenics Inc
SWB:M55
|
US |
|
Norsk Hydro ASA
OTC:NHYDY
|
NO |
|
Dufry AG
OTC:DFRYF
|
CH |
|
B
|
Babcock International Group PLC
F:BW3
|
UK |
|
B
|
Boise Cascade Co
XBER:BC0
|
US |
|
E
|
Energy Recovery Inc
SWB:5E2
|
US |
|
Q
|
Q2 Holdings Inc
SWB:0Q2
|
US |
|
A
|
ANSYS Inc
F:AKX
|
US |
|
Muenchener Rueckversicherungs Gesellschaft in Muenchen AG
XETRA:MUV2
|
DE |
|
Mitsubishi HC Capital Inc
F:5B4
|
JP |
|
A
|
Ares Commercial Real Estate Corp
F:41I
|
US |
|
D
|
DSM-Firmenich AG
OTC:DSMFF
|
CH |
|
A
|
Alamos Gold Inc
F:1AL
|
CA |
|
Evli Oyj
F:V6O
|
FI |
|
M P Evans Group PLC
F:NYP
|
UK |
|
Redcare Pharmacy NV
F:SAE1
|
NL |
Bankruptcy Probability
MacroGenics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
MacroGenics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
MacroGenics Inc
NASDAQ:MGNX
|
286.8m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
381.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
183.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
MacroGenics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, MacroGenics Inc has total debt of 70m USD. This includes both short-term (0 USD) and long-term (70m USD) debt.
You can find a full breakdown on its Balance Sheet.
